Plasma Exchange and Rituximab in the Management of Acute Occlusive Retinal Vasculopathy Secondary to Systemic Lupus Erythematosus.
Authors:
- Erika DamatoEDErika Damato
- Richard LeeRLRichard Lee
- Stephen HarperSHStephen Harper
- 4 October 2011
- journal article
- case report
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 19 (5) , 379-381
Abstract
Purpose: To report a case of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus (SLE) successfully treated with plasma exchange and rituximab Methods: Case Report Results: A 25-year-old female presenting acutely with lupus retinal vasculitis was treated urgently with plasma exchange after failure to respond to intravenous methylprednisolone. Following this, fluorescein angiography demonstrated reperfusion of occluded arterioles. Visual acuity improved from 6/60 to 6/6 bilaterally. Remission was maintained following rituximab (Rituxan) in combination with mycophenolatemofetil and oral prednisolone. Conclusions: Early treatment with plasma exchange achieved reperfusion of the occluded microvascular circulation with correspondingly good visual recovery and should be considered when patients present with corticosteroid refractory retinal vasculitis associated with SLE.Keywords
This publication has 5 references indexed in Scilit:
- Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapyLupus, 2009
- Plasma exchange for systemic lupus erythematosusTransfusion and Apheresis Science, 2007
- Plasmapheresis for Lupus Retinal VasculitisArchives of Ophthalmology (1950), 2006
- B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosusNature Clinical Practice Rheumatology, 2006
- Mechanisms of AutoimmunityImmunologic Research, 2003